Skip to main content
Journal ArticleOPEN ACCESS

Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients

Frontiers in Pharmacology (2020) 11
DOI: 10.3389/fphar.2020.01156
17Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Author supplied keywords

Cite

CITATION STYLE

APA

Zauli, G., Tisato, V., & Secchiero, P. (2020). Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients. Frontiers in Pharmacology, 11. https://doi.org/10.3389/fphar.2020.01156

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free